Suppr超能文献

血小板聚集与冷沉球蛋白M在肝炎及免疫复合物状态研究中的应用

Platelet aggregation and cryo-IgM in the study of hepatitis and immune complex states.

作者信息

Penttinen K, Wager O, Räsänen J A, Myllylä G, Haapanen E

出版信息

Clin Exp Immunol. 1973 Nov;15(3):409-16.

Abstract

Hepatitis and other sera were studied for direct platelet aggregating (P1.A.) activity in non-heated and heat-treated state, for inhibitability of P1.A. by antiglobulin active cryoglobulin IgM components (Cryo-IgM), and for sedimentation velocity of P1.A. activity by sucrose gradient centrifugation. Three distinct patterns of direct P1.A. activity were established: (1) aggregated IgG type': heating-dependent, [unk]19S, inhibitable by Cryo-IgM, serum anticomplementary; (2) antibody type': heating-independent, 7S and/or 19S, non-inhibitable by Cryo-IgM, serum not anticomplementary; and (3) `immune-complex type': heating-independent, [unk]19S, inhibitable by Cryo-IgM, anticomplementary activity present or absent. In the heavy P1.A.-active sucrose gradient serum fractions of one patient, only IgG4 Gm markers were detected.

摘要

对肝炎血清及其他血清在未加热和热处理状态下的直接血小板聚集(P1.A.)活性、抗球蛋白活性冷球蛋白IgM成分(Cryo-IgM)对P1.A.的抑制能力以及通过蔗糖梯度离心法测定P1.A.活性的沉降速度进行了研究。确定了三种不同的直接P1.A.活性模式:(1)“聚集IgG型”:依赖加热,[未知]19S,可被Cryo-IgM抑制,血清具有抗补体活性;(2)“抗体型”:不依赖加热,7S和/或19S,不能被Cryo-IgM抑制,血清无抗补体活性;(3)“免疫复合物型”:不依赖加热,[未知]19S,可被Cryo-IgM抑制,存在或不存在抗补体活性。在一名患者的重P1.A.活性蔗糖梯度血清组分中,仅检测到IgG4 Gm标记物。

相似文献

引用本文的文献

本文引用的文献

1
PLATELET SEQUESTRATION IN MAN. I. METHODS.人体中的血小板隔离。一、方法。
J Clin Invest. 1964 May;43(5):843-55. doi: 10.1172/JCI104970.
3
Soluble antigen-antibody complexes and platelet aggregation.可溶性抗原-抗体复合物与血小板聚集。
Acta Pathol Microbiol Scand. 1969;77(2):309-17. doi: 10.1111/j.1699-0463.1969.tb04236.x.
5
Platelet aggregation test in the study of hepatitis.肝炎研究中的血小板聚集试验
Am J Dis Child. 1972 Apr;123(4):418-20. doi: 10.1001/archpedi.1972.02110100150058.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验